European Archives - Page 440 of 899 - European Medical Journal

New Treatment Patch Option for Skin Cancer

INNOVATIVE development of a novel wearable patch for topical delivery of treatment for melanoma may lead to a better treatment experience for patients.

Traumatic Coronary Artery Dissection Diagnosed Immediately with Cardiac CT

The incidence of traumatic coronary artery dissection is rare, but it can be life-threatening…

Chief Digital Officers: the pioneers of cultural change

Meet the Chief Digital Officer: a person that ensures a pharmaceutical company evolves with the times through continued collaboration and culture shifts.

The metrics of medical affairs

Measuring the impact of medical affairs is less straightforward than it is for R&D or commercial, but we must establish success metrics.

Creating brand loyalty with RWE

The commercial value of RWE is yet to be realised, but the benefits extend far beyond the aisles in which it is currently in high demand.

Calling checkmate on meaningless social media

The pharma industry is dabbling in the game of social media, and it’s no secret that they need to have a better presence on these platforms.

Digital therapeutics: fad or force for change?

More and more digital therapeutics are hitting the market, taking the patient experience of healthcare into a more innovative, less invasive place, but are these digital devices worth the hype?

Talking to Dr Gino Martini

Dr Gino Martini, Chief Scientist, Royal Pharmaceutical Society, covers the rapid data generation of COVID-19, the value of digital for HCPs, and why he thinks there will be much to reflect on after the pandemic has passed.

Newborn Screening: Now and in the Future

WHAT is the value of newborn screening (NBS) to the rare diseases community?…

Driving Care Pathways into the Future

ARTIFICIAL intelligence could one day form the backbone of healthcare, but with such a powerful technology looming on our horizon, what exactly does…